NIVF logo

NewGenIvf Group Limited (NIVF) Company Overview

Profile

Full Name:

NewGenIvf Group Limited

Sector:

Healthcare

Industry:

Medical Care Facilities

Country:

Hong Kong

IPO:

March 18, 2022

Indexes:

Not included

Website:

http://newgenivf.com

Description:

NewGenIvf Group Limited is a healthcare company specializing in in vitro fertilization (IVF) and reproductive services, helping individuals and couples achieve their dreams of parenthood through advanced medical technologies and personalized care.

Key Details

Price

$1.77

Market Cap

$3.01 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$5.14 M(-13.59% YoY)

Annual EPS

$0.26(-71.61% YoY)

PE Ratio

-

Annual ROE

51.39%

Annual Debt To Equity

0.00

Beta

23.16

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

N/A

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Feb 11, 2025

Analyst ratings

Recent major analysts updates

No data about analysts updates

Screeners with NIVF included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$1.77
NIVF price is $1.77

Price All-time High

$2.58
NIVF price is currently -31.40% below its historical high of $2.58

Price Analysts Target

-
NIVF price consensus analysts' forecast is unknown

Price Most Recent Change

+41.6%
NIVF price was up +41.6% on Mar 5, 2025

Price YTD Change

-
NIVF price ytd change is unknown

Price 3-Year Change

-
NIVF price 3-year change is unknown

Market cap

Market Cap

$3.01 M
NIVF market capitalization is $3.01 million

Market Cap 3-Year Change

-
NIVF market capitalization 3-year change is unknown

Market Cap All-time High

$4.38 M
NIVF market capitalization is currently -31.40% below its historical high of $4.38 million

Market Cap Sector Rank

8.97%
NIVF market capitalization is higher than 8.97% of companies in Healthcare sector

Technical

Beta

23.16
NIVF beta is 23.16

200-day SMA

$1.55
NIVF price is currently +13.98% above its 200-day simple moving average

14-day RSI

55.46
NIVF 14-day relative strength index is 55.46

30-day Relative Volume

0.20
NIVF 30-day relative volume is 0.20

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$5.14 M
NIVF annual revenue is $5.14 million

Annual Revenue Analysts Estimate

-
NIVF annual revenue consensus analysts' forecast is unknown

Annual Revenue 1-Year Change

-13.59%
NIVF annual revenue is down -13.59% year-on-year

Annual Revenue Sector Rank

-
NIVF annual revenue is unknown

Profit

Annual Gross Profit

$1.68 M
NIVF annual gross profit is $1.68 million

Annual Gross Margin

32.74%
NIVF annual gross profit margin is 32.74%

Annual Operating Profit

$42.20 K
NIVF annual operating income is $42.20 thousand

Annual Operating Margin

0.82%
NIVF annual operating profit margin is 0.82%

Annual Net Income

$130.20 K
NIVF annual net profit is $130.20 thousand

Annual Net Margin

2.53%
NIVF annual net profit margin is 2.53%

EPS

Annual EPS

$0.26
NIVF annual earnings per share is $0.26

Annual EPS Analysts Estimate

-
NIVF annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

-71.61%
NIVF annual earnings per share is down -71.61% year-on-year

Annual EPS Sector Rank

-
NIVF annual earnings per share is unknown

ROA & ROE

Annual ROA

5.72%
NIVF annual return on assets is 5.72%

Annual ROE

51.39%
NIVF annual return on equity is 51.39%

EBIT & EBITDA

Annual EBIT

$154.60 K
NIVF annual earnings before interest & taxes is $154.60 thousand

Annual EBITDA

$384.30 K
NIVF annual EBITDA is $384.30 thousand

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
NIVF price to earnings ratio value is unknown

PE Ratio Sector Rank

-
NIVF price to earnings ratio is unknown

PB Ratio

PB Ratio

3.35
NIVF price to book ratio is 3.35

PB Ratio Sector Rank

72.94%
NIVF price to book ratio is higher than 72.94% of companies in Healthcare sector

PS Ratio

PS Ratio

-
NIVF price to sales ratio value is unknown

PS Ratio Sector Rank

-
NIVF price to sales ratio is unknown

Enterprise value

Enterprise Value

$3.28 M
NIVF enterprise value is $3.28 million

Enterprise Value Sector Rank

16.15%
NIVF enterprise value is higher than 16.15% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
NIVF EV/EBITDA value is unknown

EV/EBITDA Sector Rank

-
NIVF EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

1.07
NIVF annual current ratio is 1.07

Annual Quick Ratio

0.96
NIVF annual quick ratio is 0.96

Leverage

Annual Debt To Equity

0.00
NIVF annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

3.35
NIVF annual interest coverage ratio is 3.35

Risk & Stability

Piotroski F-Score

-
NIVF piotroski f-score value is unknown

Altman Z-Score

4.55
NIVF altman z-score is 4.55

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$1.65 M
NIVF annual total assets is $1.65 million

Annual Non Current Assets

$446.00 K
NIVF annual long term assets is $446.00 thousand

Annual Current Assets

$1.20 M
NIVF annual total current assets is $1.20 million

Annual Cash & Cash Equivalents

$54.10 K
NIVF annual cash & cash equivalents is $54.10 thousand

Equity

Annual Book Value

$896.10 K
NIVF annual book value is $896.10 thousand

Annual Working Capital

$79.00 K
NIVF annual working capital is $79.00 thousand

Liabilities

Annual Total Liabilities

$1.24 M
NIVF annual total liabilities is $1.24 million

Annual Total Long Term Liabilities

$119.00 K
NIVF annual total long term liabilities is $119.00 thousand

Annual Current Liabilities

$1.12 M
NIVF annual total current liabilities is $1.12 million

Annual Accounts Payable

$172.60 K
NIVF annual accounts payable is $172.60 thousand

Debt

Annual Total Debt

$332.60 K
NIVF annual total debt is $332.60 thousand

Annual Total Debt 1-Year Change

-26.42%
NIVF annual total debt is down -26.42% year-on-year

Annual Long Term Debt

$119.00 K
NIVF annual long term debt is $119.00 thousand

Annual Short Term Debt

$213.60 K
NIVF annual short term debt is $213.60 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$5.09 M
NIVF annual total expenses is $5.09 million

Annual Operating Expenses

$1.64 M
NIVF annual total operating expenses is $1.64 million

Annual Cost Of Goods Sold

$3.45 M
NIVF annual cost of goods sold is $3.45 million

Annual SGA

$1.64 M
NIVF annual SGA is $1.64 million

Annual D&A

$229.70 K
NIVF annual depreciation & amortization is $229.70 thousand

Annual Interest Expense

$46.20 K
NIVF annual interest expense is $46.20 thousand

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$1.77 M
NIVF annual cash flow from operations is -$1.77 million

Annual CFO 1-Year Change

-203.23%
NIVF annual cash flow from operations is down -203.23% year-on-year

Annual CFI

-$69.80 K
NIVF annual cash flow from investing activities is -$69.80 thousand

Annual CFI 1-Year Change

+26.14%
NIVF annual cash flow from investing activities is up +26.14% year-on-year

Annual CFF

$1.88 M
NIVF annual cash flow from financing activities is $1.88 million

Annual CFF 1-Year Change

+215.16%
NIVF annual cash flow from financing activities is up +215.16% year-on-year

Free CashFlow

Annual FCF

-$1.84 M
NIVF annual free cash flow is -$1.84 million

Annual FCF 1-Year Change

-213.59%
NIVF annual free cash flow is down -213.59% year-on-year

CAPEX

Annual CAPEX

$69.80 K
NIVF annual capital expenditures is $69.80 thousand

Annual CAPEX 1-Year Change

-26.14%
NIVF annual capital expenditures is down -26.14% year-on-year

Institutional Ownership

Similar stocks

HSCS logo
Heart Test Laboratories (HSCS)
LIPO logo
Lipella Pharmaceuticals (LIPO)
Klotho Neurosciences (KLTO)
NBY logo
NovaBay Pharmaceuticals (NBY)
GNPX logo
Genprex (GNPX)
TIVC logo
Tivic Health Systems (TIVC)
Scinai Immunotherapeutics (SCNI)
XRTX logo
XORTX Therapeutics (XRTX)
TLIS logo
Talis Biomedical (TLIS)

FAQ

  • What is the ticker symbol for NewGenIvf Group Limited?
  • Does NewGenIvf Group Limited pay dividends?
  • What sector is NewGenIvf Group Limited in?
  • What industry is NewGenIvf Group Limited in?
  • What country is NewGenIvf Group Limited based in?
  • When did NewGenIvf Group Limited go public?
  • Is NewGenIvf Group Limited in the S&P 500?
  • Is NewGenIvf Group Limited in the NASDAQ 100?
  • Is NewGenIvf Group Limited in the Dow Jones?
  • When does NewGenIvf Group Limited report earnings?

What is the ticker symbol for NewGenIvf Group Limited?

The ticker symbol for NewGenIvf Group Limited is NASDAQ:NIVF

Does NewGenIvf Group Limited pay dividends?

No, NewGenIvf Group Limited does not pay dividends

What sector is NewGenIvf Group Limited in?

NewGenIvf Group Limited is in the Healthcare sector

What industry is NewGenIvf Group Limited in?

NewGenIvf Group Limited is in the Medical Care Facilities industry

What country is NewGenIvf Group Limited based in?

NewGenIvf Group Limited is headquartered in Hong Kong

When did NewGenIvf Group Limited go public?

NewGenIvf Group Limited's initial public offering (IPO) was on March 18, 2022

Is NewGenIvf Group Limited in the S&P 500?

No, NewGenIvf Group Limited is not included in the S&P 500 index

Is NewGenIvf Group Limited in the NASDAQ 100?

No, NewGenIvf Group Limited is not included in the NASDAQ 100 index

Is NewGenIvf Group Limited in the Dow Jones?

No, NewGenIvf Group Limited is not included in the Dow Jones index

When does NewGenIvf Group Limited report earnings?

The date for NewGenIvf Group Limited's next earnings report has not been announced yet